Browsing publications by John Kelly

Newcastle AuthorsTitleYear
Simon Dovedi
Professor John Kirby
Dr Barry Davies
Professor Hing Leung
John Kelly
et al.		Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma2008
Professor John Kirby
John Kelly
[abstract] Polarisation of a T-helper cell immune response by CpG-oligonucleotides: a potential immunotherapy for bladder cancer2005
Simon Dovedi
Professor John Kirby
Dr Helen Maitland
Dr Barry Davies
John Kelly
et al.		Cyclooxygenase-2 inhibition: A potential mechanism for increasing the efficacy of bacillus Calmette-Guerin immunotherapy for bladder cancer2005
Jose Dominguez-Escrig
John Kelly
Professor David Neal
Dr Sonya King
Dr Barry Davies
et al.		Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer2004
Thomas Griffiths
Philip Powell
David Thomas
Professor David Neal
John Kelly
et al.		Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment2003
Dr Helen Maitland
Dr Barry Davies
Professor John Kirby
John Kelly
Polarisation of a T helper cell immune response by CpG-containing oligonucleotides: A potential immunotherapy for bladder cancer2003
Helen Atkins
Dr Barry Davies
Professor John Kirby
John Kelly
Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: A potential therapeutic regime for bladder cancer immunotherapy2003
John Kelly
Professor David Neal
Special issue: Developments and perspectives in urological oncology - Editorial2002
John Kelly
Professor David Neal
Surgical Oncology: Editorial2002
John Kelly
Effect of antisense Bcl-2 oligonucleotids on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma2001
12